TP53 and cancer: In addition to phosphorylation and acetylation, cancer-related mutations in p53 were shown to have profound effects on the efficiency of its ubiquitination, resulting in the hyperstability of p53 that might be responsible for the oncogenic activities of mutated proteoforms of this protein [216].